These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2887011)

  • 1. [Somatostatin: physiologic significance and therapeutic applications].
    Gómez-Pan A
    Rev Clin Esp; 1987 May; 180(8):413-5. PubMed ID: 2887011
    [No Abstract]   [Full Text] [Related]  

  • 2. [Somatostatin--a hypothalamic factor inhibiting the secretion of growth hormone].
    Lankosz-Lauterbach J
    Pediatr Pol; 1977 Aug; 52(8):919-23. PubMed ID: 333364
    [No Abstract]   [Full Text] [Related]  

  • 3. [Somatostatin].
    Radbil' OS
    Klin Med (Mosk); 1978 May; 56(5):28-34. PubMed ID: 207926
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of ophthalmoplegia in acromegaly with the somatostatin analogue SMS 201-995.
    van Liessum PA; Pieters GF; Hermus AR; Smals AG; Kloppenborg PW
    Neth J Med; 1988 Jun; 32(5-6):289-92. PubMed ID: 2899298
    [No Abstract]   [Full Text] [Related]  

  • 5. Short- and long-term effects of octreotide and SOM230 on GH, IGF-I, ACTH, corticosterone and ghrelin in rats.
    Schmid HA; Silva AP
    J Endocrinol Invest; 2005; 28(11 Suppl International):28-35. PubMed ID: 16625842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.
    Ma P; Wang Y; van der Hoek J; Nedelman J; Schran H; Tran LL; Lamberts SW
    Clin Pharmacol Ther; 2005 Jul; 78(1):69-80. PubMed ID: 16003295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin: its role in health and disease.
    Gottesman IS; Mandarino LJ; Gerich JE
    Spec Top Endocrinol Metab; 1982; 4():177-243. PubMed ID: 6134345
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypothalamic releasing hormones. I. Structure, sources of formation, physiologic effects].
    Dedov II; Dedov VI
    Usp Sovrem Biol; 1980; 89(1):141-58. PubMed ID: 6104883
    [No Abstract]   [Full Text] [Related]  

  • 9. Somatostatin and growth hormone regulation in cancer.
    Manni A
    Biotherapy; 1992; 4(1):31-6. PubMed ID: 1347453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment of acromegaly with a somatostatin analog].
    Vest S
    Ugeskr Laeger; 1987 Aug; 149(34):2263. PubMed ID: 2897734
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatostatin analogs inhibit neonatal retinal neovascularization.
    Higgins RD; Yan Y; Schrier BK
    Exp Eye Res; 2002 May; 74(5):553-9. PubMed ID: 12076076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
    Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
    JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities of medical treatment in acromegaly].
    Cáp J; Nemecek S; Rezácová M; Cerman J
    Cas Lek Cesk; 2005; 144 Suppl 3():33-4, 36-7. PubMed ID: 16335261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of modulation of GH/IGF-I axis in the development of diabetic proliferative retinopathy.
    Genovese S; Riccardi G
    J Endocrinol Invest; 2003; 26(8 Suppl):114-6. PubMed ID: 15233225
    [No Abstract]   [Full Text] [Related]  

  • 15. Inadequate growth hormone (GH) suppression following an octreotide test dose predicts the need for adjuvant therapy to achieve 'safe' GH levels.
    Aylwin S
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):133. PubMed ID: 16817834
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic applications of somatostatin and its analogue octreotide.
    Harris AG; Kokoris SP
    Eur J Med; 1993 Feb; 2(2):97-105. PubMed ID: 7903061
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of somatostatin and octreotide on experimental and human acute pancreatitis.
    Greenberg R; Haddad R; Kashtan H; Kaplan O
    J Lab Clin Med; 2000 Feb; 135(2):112-21. PubMed ID: 10695655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some changes of receptor and postreceptor signal transduction regulated by somatostatin in pituitary hGH-secreting adenomas.
    Deng J; Shi Y; Yin J
    Chin Med J (Engl); 1997 Sep; 110(9):678-81. PubMed ID: 9642323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Somatostatin analogues for the treatment of gastro-entero-pancreatic neuroendocrine tumours].
    Uomo G; Germano D; Rabitti PG
    Minerva Endocrinol; 2001 Dec; 26(4):225-9. PubMed ID: 11782707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of somatostatin receptor ligands in obesity and diabetic complications.
    Boehm BO; Lustig RH
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):493-509. PubMed ID: 12079271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.